profile Company

Mustaqbalka Novartis

#
Rank
182
| Quantumrun Global 1000

Novartis International AG waa shirkad caalami ah oo dawooyinka Swiss ah oo fadhigeedu yahay Basel, Switzerland. Waa mid ka mid ah shirkadaha dawooyinka ee ugu weyn ee iibka iyo suuqa labadaba. Novartis waxay soo saartaa dawooyinka carbamazepine (Tegretol), imatinib mesylate (Gleevec/Glivec), clozapine (Clozaril), diclofenac (Voltaren), iyo valsartan (Diovan). Waxyaalaha dheeraadka ah waxaa ka mid ah letrozole (Femara), terbinafine (Lamisil), ciclosporin (Neoral/Sandimmun), methylphenidate (Ritalin), iyo kuwo kale.

Dalka Hooyo:
Warshadaha:
daawooyinka
Website:
aasaasay:
1996
Tirada shaqaalaha adduunka:
118393
Tirada shaqaalaha guriga:
Tirada goobaha guriga:
6

Caafimaadka Maaliyadda

Dakhliga:
$48518000000 USD
celceliska dakhliga 3y:
$50037333333 USD
Kharashaadka hawlgalka:
$25575000000 USD
celceliska kharashyada 3y:
$26073666667 USD
Lacagaha kaydka ah:
$7777000000 USD

Waxqabadka Hantida

  1. Alaabta/Adeegga/Dept. magac
    Daawooyin cusub
    Dakhliga badeecada/Adeegga
    32562000000
  2. Alaabta/Adeegga/Dept. magac
    Sandoz
    Dakhliga badeecada/Adeegga
    10144000000
  3. Alaabta/Adeegga/Dept. magac
    Alcon
    Dakhliga badeecada/Adeegga
    5812000000

Hantida hal-abuurka iyo Dhuumaha

Darajada summada caalamka:
462
Maalgelinta R&D:
$2645000000 USD
Wadarta shatiyada la haysto:
1

Dhammaan xogta shirkadda laga soo ururiyey warbixinteeda sannadlaha ah ee 2016 iyo ilo kale oo dadweyne. Saxnaanta xogtan iyo gabagabada laga soo qaatay waxay ku xidhan tahay xogtan si guud loo heli karo. Haddii barta xogta ee kor ku taxan la ogaado in aanay sax ahayn, Quantumrun waxa ay ku samayn doontaa sixitaannada lagama maarmaanka ah boggan tooska ah. 

NAYLKA KHASAADU

Lahaanshaha qaybta daryeelka caafimaadka waxay la macno tahay in shirkaddan ay si toos ah iyo si dadbanba u saamayn doonto tiro ka mid ah fursadaha carqaladaynta iyo caqabadaha tobannaanka sano ee soo socda. Iyadoo si faahfaahsan loogu sharraxay warbixinnada gaarka ah ee Quantumrun, isbeddelladan carqaladaynta ah ayaa lagu soo koobi karaa qodobbada ballaadhan ee soo socda:

* Marka hore, dabayaaqada 2020s waxay arki doonaan jiilalka aamusan iyo kuwa Boomerka ah oo si qoto dheer u galaya sannadahooda sare. Matalaya ku dhawaad ​​30-40 boqolkiiba dadweynaha caalamka, isku darka tirada dadka ayaa ka dhigan culeys weyn oo dhanka nidaamyada caafimaadka ah ee wadamada horumaray. * Si kastaba ha ahaatee, sidii qof ku hawlan oo qani ah oo codaynta ah, tirakoobkani waxa uu si firfircoon ugu codayn doonaa korodhka kharashka dadweynaha ee adeegyada caafimaadka la kabka ah (cisbitaallada, daryeelka degdegga ah, guryaha dadka lagu xanaaneeyo, iwm.) si ay u taageeraan sannadaha cirridka.
* Cadaadiska dhaqaale ee sababay tirada dadka waayeelka ah ee weyn waxay ku dhiirigelin doontaa wadamada horumaray inay si degdeg ah ula socdaan nidaamka tijaabinta iyo ansixinta daawooyinka cusub, qalliinnada iyo borotokoolka daaweynta kuwaas oo hagaajin kara guud ahaan caafimaadka jireed iyo maskaxeed ee bukaannada ilaa heer ay u horseedi karaan madax bannaan ku nool meel ka baxsan nidaamka daryeelka caafimaadka.
*Maalgelintan korodhay ee lagu galay nidaamka daryeelka caafimaadka waxa ka mid ah in xooga la saaro daawada ka hortagga iyo daawaynta.
* Horraantii 2030-meeyadii, daawaynta daryeelka caafimaadka ee ugu qoto dheer ayaa la heli doonaa: daawayn lagu dhimo oo hadhow dib loogu celiyo saamaynta gabowga. Daawayntan ayaa la bixin doonaa sanad walba, muddo ka dib, waxay noqon doontaa mid ay awoodi karaan dadweynaha. Kacaanka caafimaadku waxa uu keeni doonaa hoos u dhac ku yimaada isticmaalka iyo culayska nidaamka guud ee daryeelka caafimaadka-maadaama dadka da'da yar/jidhku isticmaalaan ilo daryeel caafimaad ka yar, celcelis ahaan, marka loo eego dadka da'da ah, jirkooda buka.
*Sida sii kordheysa, waxaan isticmaali doonaa hababka sirdoonka macmal ah ee lagu baaro bukaanada iyo robots si loo maareeyo qalliinada adag.
*Dhammaadka 2030-meeyadii, qalabka tignoolajiyada lagu rakibo ayaa sixi doona dhaawac kasta oo jidheed, halka galinta maskaxda iyo dawooyinka xusuusta tirtira ay daweyn doonaan inta badan dhaawac kasta oo maskaxeed ama jirro.
* Badhtamaha 2030-meeyadii, dhammaan dawooyinka waxa lagu habayn doonaa genome-kaaga gaarka ah iyo microbiome-kaaga.

RAJADA MUSTAQBALKA SHIRKADA

Cinwaanka Shirkadda